Cerebral Embolic Protection Devices for TAVI Market Share, Sales Volume, Price Analysis Report 2026
公開 2025/12/10 11:38
最終更新
-
On Dec 10, Global Info Research released "Global Cerebral Embolic Protection Devices for TAVI Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032". This report includes an overview of the development of the Cerebral Embolic Protection Devices for TAVI industry chain, the market status of Cerebral Embolic Protection Devices for TAVI Market, and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cerebral Embolic Protection Devices for TAVI.
Transcatheter aortic valve implantation (TAVI), also known as TAVR or Transcatheter aortic valve replacement is used in the treatment of aortic stenosis (AS). Transcatheter aortic valve implantation is the therapy of choice for patients with severe aortic stenosis who have prohibitive or high surgical risk. However, the benefit of TAVI is attenuated by the occurrence of major disabling stroke which is associated with increased mortality and early-reduced quality of life. Despite advances in TAVI technology, stroke remains a serious complication that is associated with significant negative outcomes. The majority of these occur in the acute phase following TAVI where cerebral embolic events are frequent. Cerebral embolic protection devices (CEPD) have been developed to minimize the risk of peri-procedural ischemic stroke during TAVI.
TAVI (transcatheter aortic valve implantation), as a minimally invasive treatment for high-risk elderly patients or patients with surgical risks, has become one of the important breakthroughs in the cardiovascular field in recent years. TAVI technology has not only significantly improved the safety and effectiveness of valve replacement therapy, but also greatly improved the quality of life of patients. However, there are certain risks in the TAVI operation, especially the risk of cerebral embolism, which has always been a challenge in clinical treatment. In order to effectively reduce the cerebral embolic events that may occur during TAVI surgery, cerebral embolic protection devices (CEPDs) came into being and became an important technical means to ensure the safety of TAVI treatment and patient prognosis.
At present, with the widespread application and acceptance of TAVI technology, the market demand for cerebral embolic protection devices is also growing. During TAVI surgery, especially when valve implantation is performed through the femoral artery, tiny blood clots may fall off due to the operation of the valve implanter and catheter, thereby causing cerebral embolism. This cerebral embolic event can cause stroke or other neurological complications, affecting the patient's prognosis. In order to effectively prevent this risk, CEPDs came into being and quickly became one of the standard configurations in TAVI surgery.
Brain
Globally, the European and American markets started early in the application of TAVI technology and related protection devices, and the market acceptance is high. Especially in the United States and Europe, more and more TAVI surgeries are beginning to routinely use cerebral embolic protection devices. In China and other Asian regions, with the gradual popularization of TAVI technology, the market demand for cerebral embolic protection devices is also rising. Although it is still in its infancy compared to the European and American markets, with the continuous advancement of medical technology and health concepts, the market potential is huge.
Venus Medtech (Keystone Heart) is the largest manufacturer of cerebral embolic protection devices for TAVI in the world, has a share of over 90%. Geographically speaking, cerebral embolic protection devices for TAVI currently have a market only in Europe and North America, with North America accounting for about 55% of the share. In terms of artery coverage cover, non-total artery coverage segment holds an important share of over 90%. In terms of application, hospital segment accounts for about 80% of the global share.
This report is a detailed and comprehensive analysis for global Cerebral Embolic Protection Devices for TAVI market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Sample Report Request Cerebral Embolic Protection Devices for TAVI
https://www.globalinforesearch.com/reports/3382816/cerebral-embolic-protection-devices-for-tavi
Market segment by Type: Total Artery Coverage、 Non-total Artery Coverage
Market segment by Application: Hopsital、 Others
Major players covered: Boston Scientific (Claret Medical)、 Venus Medtech (Keystone Heart)、 Transverse Medical、 Emboline、 Protembis GmbH、 Filterlex Medical
Market segment by region, regional analysis covers:
North America (United States, Canada and Mexico),
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe),
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia),
South America (Brazil, Argentina, Colombia, and Rest of South America),
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa).
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cerebral Embolic Protection Devices for TAVI product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cerebral Embolic Protection Devices for TAVI, with price, sales, revenue and global market share of Cerebral Embolic Protection Devices for TAVI from 2021 to 2025.
Chapter 3, the Cerebral Embolic Protection Devices for TAVI competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cerebral Embolic Protection Devices for TAVI breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2021 to 2025.and Cerebral Embolic Protection Devices for TAVI market forecast, by regions, type and application, with sales and revenue, from 2026 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cerebral Embolic Protection Devices for TAVI.
Chapter 14 and 15, to describe Cerebral Embolic Protection Devices for TAVI sales channel, distributors, customers, research findings and conclusion.
Data Sources:
Via authorized organizations:customs statistics, industrial associations, relevant international societies, and academic publications etc.
Via trusted Internet sources.Such as industry news, publications on this industry, annual reports of public companies, Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), Trading Economics, News Network, Statista, Federal Reserve Economic Data, BIS Statistics, ICIS, Companies House Documentsm, investor presentations, SEC filings of companies, etc.
Via interviews. Our interviewees includes manufacturers, related companies, industry experts, distributors, business (sales) staff, directors, CEO, marketing executives, executives from related industries/organizations, customers and raw material suppliers to obtain the latest information on the primary market;
Via data exchange. We have been consulting in this industry for 16 years and have collaborations with the players in this field. Thus, we get access to (part of) their unpublished data, by exchanging with them the data we have.
From our partners.We have information agencies as partners and they are located worldwide, thus we get (or purchase) the latest data from them.
Via our long-term tracking and gathering of data from this industry.We have a database that contains history data regarding the market.
About Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
Transcatheter aortic valve implantation (TAVI), also known as TAVR or Transcatheter aortic valve replacement is used in the treatment of aortic stenosis (AS). Transcatheter aortic valve implantation is the therapy of choice for patients with severe aortic stenosis who have prohibitive or high surgical risk. However, the benefit of TAVI is attenuated by the occurrence of major disabling stroke which is associated with increased mortality and early-reduced quality of life. Despite advances in TAVI technology, stroke remains a serious complication that is associated with significant negative outcomes. The majority of these occur in the acute phase following TAVI where cerebral embolic events are frequent. Cerebral embolic protection devices (CEPD) have been developed to minimize the risk of peri-procedural ischemic stroke during TAVI.
TAVI (transcatheter aortic valve implantation), as a minimally invasive treatment for high-risk elderly patients or patients with surgical risks, has become one of the important breakthroughs in the cardiovascular field in recent years. TAVI technology has not only significantly improved the safety and effectiveness of valve replacement therapy, but also greatly improved the quality of life of patients. However, there are certain risks in the TAVI operation, especially the risk of cerebral embolism, which has always been a challenge in clinical treatment. In order to effectively reduce the cerebral embolic events that may occur during TAVI surgery, cerebral embolic protection devices (CEPDs) came into being and became an important technical means to ensure the safety of TAVI treatment and patient prognosis.
At present, with the widespread application and acceptance of TAVI technology, the market demand for cerebral embolic protection devices is also growing. During TAVI surgery, especially when valve implantation is performed through the femoral artery, tiny blood clots may fall off due to the operation of the valve implanter and catheter, thereby causing cerebral embolism. This cerebral embolic event can cause stroke or other neurological complications, affecting the patient's prognosis. In order to effectively prevent this risk, CEPDs came into being and quickly became one of the standard configurations in TAVI surgery.
Brain
Globally, the European and American markets started early in the application of TAVI technology and related protection devices, and the market acceptance is high. Especially in the United States and Europe, more and more TAVI surgeries are beginning to routinely use cerebral embolic protection devices. In China and other Asian regions, with the gradual popularization of TAVI technology, the market demand for cerebral embolic protection devices is also rising. Although it is still in its infancy compared to the European and American markets, with the continuous advancement of medical technology and health concepts, the market potential is huge.
Venus Medtech (Keystone Heart) is the largest manufacturer of cerebral embolic protection devices for TAVI in the world, has a share of over 90%. Geographically speaking, cerebral embolic protection devices for TAVI currently have a market only in Europe and North America, with North America accounting for about 55% of the share. In terms of artery coverage cover, non-total artery coverage segment holds an important share of over 90%. In terms of application, hospital segment accounts for about 80% of the global share.
This report is a detailed and comprehensive analysis for global Cerebral Embolic Protection Devices for TAVI market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Sample Report Request Cerebral Embolic Protection Devices for TAVI
https://www.globalinforesearch.com/reports/3382816/cerebral-embolic-protection-devices-for-tavi
Market segment by Type: Total Artery Coverage、 Non-total Artery Coverage
Market segment by Application: Hopsital、 Others
Major players covered: Boston Scientific (Claret Medical)、 Venus Medtech (Keystone Heart)、 Transverse Medical、 Emboline、 Protembis GmbH、 Filterlex Medical
Market segment by region, regional analysis covers:
North America (United States, Canada and Mexico),
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe),
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia),
South America (Brazil, Argentina, Colombia, and Rest of South America),
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa).
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cerebral Embolic Protection Devices for TAVI product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cerebral Embolic Protection Devices for TAVI, with price, sales, revenue and global market share of Cerebral Embolic Protection Devices for TAVI from 2021 to 2025.
Chapter 3, the Cerebral Embolic Protection Devices for TAVI competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cerebral Embolic Protection Devices for TAVI breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2021 to 2025.and Cerebral Embolic Protection Devices for TAVI market forecast, by regions, type and application, with sales and revenue, from 2026 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cerebral Embolic Protection Devices for TAVI.
Chapter 14 and 15, to describe Cerebral Embolic Protection Devices for TAVI sales channel, distributors, customers, research findings and conclusion.
Data Sources:
Via authorized organizations:customs statistics, industrial associations, relevant international societies, and academic publications etc.
Via trusted Internet sources.Such as industry news, publications on this industry, annual reports of public companies, Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), Trading Economics, News Network, Statista, Federal Reserve Economic Data, BIS Statistics, ICIS, Companies House Documentsm, investor presentations, SEC filings of companies, etc.
Via interviews. Our interviewees includes manufacturers, related companies, industry experts, distributors, business (sales) staff, directors, CEO, marketing executives, executives from related industries/organizations, customers and raw material suppliers to obtain the latest information on the primary market;
Via data exchange. We have been consulting in this industry for 16 years and have collaborations with the players in this field. Thus, we get access to (part of) their unpublished data, by exchanging with them the data we have.
From our partners.We have information agencies as partners and they are located worldwide, thus we get (or purchase) the latest data from them.
Via our long-term tracking and gathering of data from this industry.We have a database that contains history data regarding the market.
About Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
